Thomas Flohr

2.7k total citations
35 papers, 1.9k citations indexed

About

Thomas Flohr is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine. According to data from OpenAlex, Thomas Flohr has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Public Health, Environmental and Occupational Health and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Thomas Flohr's work include Acute Lymphoblastic Leukemia research (12 papers), Cancer Genomics and Diagnostics (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Thomas Flohr is often cited by papers focused on Acute Lymphoblastic Leukemia research (12 papers), Cancer Genomics and Diagnostics (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). Thomas Flohr collaborates with scholars based in Germany, United States and Japan. Thomas Flohr's co-authors include Claus R. Bartram, Ulrich H. Koszinowski, Hartmut Hengel, Walter Muranyi, Martin Schrappe, Martin Stanulla, Günter J. Hämmerling, Jens‐Oliver Koopmann, Frank Momburg and Els Goulmy and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Immunity.

In The Last Decade

Thomas Flohr

34 papers receiving 1.9k citations

Peers

Countries citing papers authored by Thomas Flohr

Since Specialization

Citations

This map shows the geographic impact of Thomas Flohr's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Flohr with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Flohr more than expected).

Fields of papers citing papers by Thomas Flohr

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Flohr. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Flohr. The network helps show where Thomas Flohr may publish in the future.

Co-authorship network of co-authors of Thomas Flohr

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Flohr. A scholar is included among the top collaborators of Thomas Flohr based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Flohr. Thomas Flohr is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rituximab combined with DexaBEAM followed by high dose therapy as salvage therapy in patients with relapsed or refractory B‐cell lymphoma: mature results of a phase II multicentre study 2014 ·British Journal of Haematology ·(unknown), Thomas Flohr, (unknown), Norbert Frickhofen, Martin Gramatzki, Hartmut Link, Nadežda Basara, Norma Peter, Ralf G. Meyer, Norbert Schmitz, Eckhart Weidmann, (unknown), Andrea Schulz, Karin Kolbe, G. Derigs, Matthias Theobald, Georg Heß	10
2	Quantification of free total plasma DNA and minimal residual disease detection in the plasma of children with acute lymphoblastic leukemia 2009 ·Annals of Hematology ·(unknown), Martin Stanulla, Gunnar Cario, Thomas Flohr, Rosemary Sutton, Anja Möricke, Philippe Anker, Maurice Stroun, Karl Welte, Claus R. Bartram, Martin Schrappe, André Schrauder	26
3	Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high resolution single nucleotide polymorphism oligonucleotide microarray. 2007 ·Cancer Research ·Norihiko Kawamata, Seishi Ogawa, Martin Zimmermann, Masashi Sanada, Kari Hemminki, (unknown), Yasuhito Nannya, Rolf Koehler, Thomas Flohr, Carl W. Miller, Jochen Harbott, Wolf‐Dieter Ludwig, Martin Stanulla, Martin Schrappe, Claus R. Bartram, Phillip Koeffler	4
4	Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray 2007 ·Blood ·Norihiko Kawamata, Seishi Ogawa, Martin Zimmermann, Motohiro Kato, Masashi Sanada, Kari Hemminki, (unknown), Yasuhito Nannya, Rolf Koehler, Thomas Flohr, Carl W. Miller, Jochen Harbott, Wolf-Dieter Ludwig, Martin Stanulla, Martin Schrappe, Claus R. Bartram, H. Phillip Koeffler	160
5	Prospective Evaluation of MRD-Kinetics in 274 Children with High-Risk ALL Treated in Trial ALL-BFM 2000: Insights into Development of Resistance and Impact on Further Refinement of Treatment Stratification Strategies. 2007 ·Blood ·André Schrauder, Martin Stanulla, Thomas Flohr, Gunnar Cario, Rolf Köhler, Renate Panzer‐Grümayer, Beat W. Schäfer, Martin Zimmermann, Christina Peters, Claus R. Bartram, Martin Schrappe	4
6	Minimal residual disease analysis in children with t(12;21)-positive acute lymphoblastic leukemia: comparison of Ig/TCR rearrangements and the genomic fusion gene. 2006 ·PubMed ·Markus Metzler, Georg Mann, (unknown), (unknown), Christine M. Gall, Thomas Flohr, Susanne Viehmann, Thorsten Langer, Martin Schrappe, Helmut Gadner, Oskar A. Haas, E. Renate Panzer-Grümayer	14
7	Effect of rituximab on the long-term outcome after high-dose therapy for relapsed B-cell non-Hodgkin’s lymphoma 2006 ·Annals of Hematology ·Georg Heß, Thomas Flohr, Karin Kolbe, (unknown), Martin Schüler, Hans Günter Derigs, Christoph Huber	10
8	Inv(11)(q21q23) Fuses MLL to the NOTCH Co-Activator Mastermind-Like 2 in Secondary T Cell Acute Lymphoblastic Leukemia. 2006 ·Blood ·Markus Metzler, Jan Zuna, Martin S. Staege, Lana Harder, Claus Meyer, Thomas Flohr, Joerg J Meerpohl, Eva Froňková, Thorsten Langer, Jochen Harbott, Jan Trka, Reiner Siebert, Rolf Marschalek, Charlotte M. Niemeyer, Wolfgang Rascher	2
9	Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia 2005 ·Blood ·Monika Brüggemann, Thorsten Raff, Thomas Flohr, Nicola Gökbuget, Makoto Nakao, (unknown), Silke Lüschen, Christiane Pott, Matthias Ritgen, Urban Scheuring, Heinz‐August Horst, Eckhard Thiel, Dieter Hoelzer, Claus R. Bartram, Michael Kneba	388
10	Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia 2004 ·Blood ·Gunnar Cario, Martin Stanulla, Bernard M. Fine, Oliver Teuffel, Nils von Neuhoff, André Schrauder, Thomas Flohr, Beat W. Schäfer, Claus R. Bartram, Karl Welte, Brigitte Schlegelberger, Martin Schrappe	107
11	Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia 2002 ·Best Practice & Research Clinical Haematology ·Tomasz Szczepański, Thomas Flohr, Vincent H. J. van der Velden, Claus R. Bartram, Jacques J. M. van Dongen	50
12	Association between the 5′ UTR variant C178T of the serotonin receptor gene HTR3A and bipolar affective disorder 2001 ·Pharmacogenetics ·Beate Niesler, Thomas Flohr, Markus M. Nöthen, Christine Fischer, Marcella Rietschel, Ernst Franzek, Margot Albus, Peter Propping, Gudrun Rappold	96
13	CD34 ⁺ Cell Enrichment for Autologous Peripheral Blood Stem Cell Transplantation by Use of the CliniMACS Device 2000 ·Journal of Hematotherapy & Stem Cell Research ·(unknown), Thomas Flohr, M. Uppenkamp, M. Baldus, Martin Hoffmann, C. Huber, Hans Günter Derigs	35
14	Mutation analysis of replicative genes encoding the large subunits of DNA polymerase ? and replication factors A and C in human sporadic colorectal cancers 2000 ·International Journal of Cancer ·Odilia Popanda, (unknown), (unknown), (unknown), Thomas Flohr, (unknown), Heinz Walter Thielmann	20
15	Detection of mutations in the DNA polymerase ? gene of human sporadic colorectal cancers and colon cancer cell lines 1999 ·International Journal of Cancer ·Thomas Flohr, Juncheng Dai, (unknown), Odilia Popanda, (unknown), Heinz Walter Thielmann	62
16	A mutation detected in DNA polymerase δ cDNA from Novikoff hepatoma cells correlates with abnormal catalytic properties of the enzyme 1999 ·Journal of Cancer Research and Clinical Oncology ·Odilia Popanda, Thomas Flohr, (unknown), Heinz Walter Thielmann	12
17	A Mouse Cytomegalovirus Glycoprotein Retains MHC Class I Complexes in the ERGIC/cis-Golgi Compartments 1997 ·Immunity ·H. Ziegler, (unknown), Pero Lučin, Walter Muranyi, Thomas Flohr, Hartmut Hengel, Helen E. Farrell, William D. Rawlinson, Ulrich H. Koszinowski	216
18	A Viral ER-Resident Glycoprotein Inactivates the MHC-Encoded Peptide Transporter 1997 ·Immunity ·Hartmut Hengel, Jens‐Oliver Koopmann, Thomas Flohr, Walter Muranyi, Els Goulmy, Günter J. Hämmerling, Ulrich H. Koszinowski, Frank Momburg	266
19	An interferon‐induced protein with release factor activity is a tryptophanyl‐tRNA synthetase 1992 ·FEBS Letters ·(unknown), Thomas Flohr, (unknown), Erik C. Böttger	30
20	Interferon‐γ regulates expression of a novel keratin classe I gene 1992 ·European Journal of Immunology ·Thomas Flohr, (unknown), Bernd Bonnekoh, Thomas Decker, Erik C. Böttger	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact